SEC Form 4/A · accession 0001140361-16-046992
Arbutus Biopharma Corp · ABUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael J. Abrams
Officer — Managing Director
Period of report
Jul 9, 2015
Accepted (ET)
Jan 6, 2016 · 7:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001447028
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $17.57 | Jul 9, 2015 | A | 35,000 | A | — | Mar 30, 2025 | Common shares | 35,000 | 35,000 | D |
Explanation of responses
- F1The option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018.
Remarks
2. Form 4 amendment is being filed solely to correct the title of the reporting person.